Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Cell Culture Media, Sera, and Reagents Market by Medium (Chemically Defined Media, Classical Media, Lysogeny Broth, Protein-Free Media, Serum-Free Media, Specialty Media); by Serum (Fetal Bovine, Newborn Calf and Adult Bovine Sera, Others); by Reagent [Albumin (Bovine Serum Albumin, Human Serum Albumin, Recombinant Serum Albumin), Amino Acids, Attachment Factors, Growth Factors and Cytokines (Interleukins and Interferons, Insulin-Like Growth Factors, Tumor Necrosis Factor, Others); by Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others), Others (Porcine Trypsin, Recombinant Trypsin, Thrombin, Miscellaneous Reagents)] Forecast 2024-2031

$3,000.00

Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

There are different media requirement for various cell types. Serum based media are widely used to grow a broad range of animal cell lines. Serum is a complex mix of albumins, growth factors and growth inhibitors which is also a source of amino acids, proteins, vitamins (A, D, E, and K), carbohydrates, lipids, hormones, growth factors, minerals, and trace elements.

Cell culture is one of the key tools used in molecular and cellular biology to study the physiology and biochemistry of cells (aging and metabolic studies), the effect of biomolecules and drugs on the cells, and carcinogenesis and mutagenesis studies.

Cell culture components or reagents provide an ideal growth environment as per the cell types. The global cell culture media, sera and reagents market is witnessing impressive growth due to the increase in demand for biopharmaceutical products.

The global cell culture media, sera, reagents market report estimates the market size ($million 2021 to 2031) and forecast (CAGR%, 2024 to 2031).

The global market is segmented by media type (chemically defined media, classical media, lysogeny broth, protein-free media, serum-free media, specialty media), serum type (fetal bovine, newborn calf and adult bovine sera, others), reagent type [albumin (bovine serum albumin, human serum albumin, recombinant serum albumin), amino acids, attachment factors, growth factors and cytokines (interleukins and interferons, insulin-like growth factors, tumor necrosis factor, others), hormones (insulin, recombinant insulin, erythropoietin, others), other products (porcine trypsin, recombinant trypsin, thrombin, miscellaneous reagents)], and geography.

The global cell culture media, sera, reagents market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The global cell culture media, sera, reagents market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global cell culture media, sera, reagents market and included in this report are Becton, Dickinson and Company, Corning Life Sciences B.V., EMD Millipore, GE Healthcare, Lonza Group Ltd., PromoCell GmbH, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific, Inc., VWR International, LLC, and Wheaton Industries, Inc.

DATA INCLUDED: Cell Culture Media Sera Reagents Market Size, Cell Culture Media Sera Reagents Market Share, Cell Culture Media Sera Reagents Market Growth Rates, Cell Culture Media Sera Reagents Market Trends, and Cell Culture Media Sera Reagents Market Forecast to 2031

Market Data:

  • Base year for estimation: 2023
  • Actual estimates/Historical data: 2021-2031
  • Forecast period: 2024-2031
  • Market representation: Revenue in $million and CAGR % from 2024 to 2031
  • Regional scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE and others.
  • Report coverage: Revenue forecast, company share, competitive landscape, growth factors, and trends
  • 15% free customization scope: Any specific or custom requirements, which is not currently within the scope of the report, will be provided as a part of customization.

Qualitative Analysis:

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Key market opportunities
  • Market size
  • Growth trends
  • Porter’s five forces analysis
  • Market attractiveness analysis
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product portfolio
    • Strategic insights
    • Recent developments

Quantitative Analysis:

  • Market size estimates and forecast for all segments
  • Regional market size estimated and forecast for major countries
  • Company financial performance
  • Competitive landscape: Company market share analysis

Please contact us for offers on individual or multiple report purchases.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2021-2031)
    • Forecast Estimation ($million and CAGR%, 2024-2031)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What are the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Cell Culture Media, Sera, Reagents Market

1. Media Type
1.1. Chemically Ddefined
1.2. Classical
1.3. Lysogeny Broth (LB)
1.4. Protein-free
1.5. Serum-free
1.6. Specialty Media

2. Serum Type
2.1. Fetal Bovine
2.2. Newborn Calf and Adult Bovine Sera
2.3. Others

3. Reagents Type
3.1. Albumin
3.1.1. Bovine Serum Albumin (BSA)
3.1.2. Human Serum Albumin (HSA)
3.1.3. Recombinant Serum Albumin (RSA)
3.2. Amino Acids
3.3. Attachment Factors
3.4. Growth Factors & Cytokines
3.4.1. Interleukins and Interferons
3.4.2. Insulin-like Growth Factors (IGF)
3.4.3. Tumor Necrosis Factor (TNF)
3.4.4. Others
3.5. Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
3.6. Others
3.6.1. Porcine Trypsin
3.6.2. Recombinant Trypsin
3.6.3. Thrombin
3.6.4. Miscellaneous Reagents

4. Company Profiles
4.1. Becton, Dickinson and Company
4.2. Corning Life Sciences B.V.
4.3. EMD Millipore
4.4. GE Healthcare
4.5. Lonza Group Ltd.
4.6. PromoCell GmbH
4.7. Sigma-Aldrich Co. LLC
4.8. Thermo Fisher Scientific, Inc.
4.9. VWR International, LLC
4.10. Wheaton Industries, Inc.

    Request ToC / Sample Report

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com